SULT1E1 and ID2 genes as candidates for inherited predisposition to breast and ovarian cancer in Jewish women
- PMID: 18821033
- DOI: 10.1007/s10689-008-9218-4
SULT1E1 and ID2 genes as candidates for inherited predisposition to breast and ovarian cancer in Jewish women
Abstract
Mutations in currently known genes account for only a subset of breast/ovarian cancer risk families. Three loci (2p, 4q, 22q) seemingly harbor breast cancer susceptibility genes. To explore their putative role in Jewish women, 46 affected women representing 22 high risk families were genotyped with D2S2211, D4S392, D22S278 and D22S283 and two flanking markers for each locus, and mutational analysis of ID2 (Chromosome 2) and SULT1E1 (Chromosome 4) genes was carried out in seemingly linked families. No ID2 gene mutations were detected in 8 women from the 4 families seemingly linked to D2S2211, whereas a missense mutation (His224Gln) in one affected woman from a single family was detected among 9 women from the 4 families linked to D4S392. This mutation was not found among 153 high risk, 98 sporadic breast/ovarian cancer patients, or 97 healthy controls. The SULT1E1 gene may need to be further explored as candidate breast cancer gene.
Similar articles
-
Germline CHEK2 mutations in Jewish Ashkenazi women at high risk for breast cancer.Isr Med Assoc J. 2007 Nov;9(11):791-6. Isr Med Assoc J. 2007. PMID: 18085035
-
Germline mutations in RAD51C in Jewish high cancer risk families.Breast Cancer Res Treat. 2012 Dec;136(3):869-74. doi: 10.1007/s10549-012-2317-9. Epub 2012 Nov 2. Breast Cancer Res Treat. 2012. PMID: 23117857
-
A low frequency of non-founder BRCA1 mutations in Ashkenazi Jewish breast-ovarian cancer families.Hum Mutat. 2002 Nov;20(5):352-7. doi: 10.1002/humu.10123. Hum Mutat. 2002. PMID: 12402332
-
Peritoneal carcinoma in women with genetic susceptibility: implications for Jewish populations.Fam Cancer. 2004;3(3-4):265-81. doi: 10.1007/s10689-004-9554-y. Fam Cancer. 2004. PMID: 15516851 Review.
-
Hereditary breast cancer in Jews.Fam Cancer. 2004;3(3-4):249-57. doi: 10.1007/s10689-004-9550-2. Fam Cancer. 2004. PMID: 15516849 Review.
Cited by
-
Impact of Human SULT1E1 Polymorphisms on the Sulfation of 17β-Estradiol, 4-Hydroxytamoxifen, and Diethylstilbestrol by SULT1E1 Allozymes.Eur J Drug Metab Pharmacokinet. 2021 Jan;46(1):105-118. doi: 10.1007/s13318-020-00653-1. Eur J Drug Metab Pharmacokinet. 2021. PMID: 33064293 Free PMC article.
-
SULT genetic polymorphisms: physiological, pharmacological and clinical implications.Expert Opin Drug Metab Toxicol. 2021 Jul;17(7):767-784. doi: 10.1080/17425255.2021.1940952. Epub 2021 Jun 30. Expert Opin Drug Metab Toxicol. 2021. PMID: 34107842 Free PMC article. Review.
-
From Steroid and Drug Metabolism to Glycobiology, Using Sulfotransferase Structures to Understand and Tailor Function.Drug Metab Dispos. 2022 Jul;50(7):1027-1041. doi: 10.1124/dmd.121.000478. Epub 2022 Feb 22. Drug Metab Dispos. 2022. PMID: 35197313 Free PMC article. Review.
-
Local estrogen metabolism in epithelial ovarian cancer suggests novel targets for therapy.J Steroid Biochem Mol Biol. 2015 Jun;150:54-63. doi: 10.1016/j.jsbmb.2015.03.010. Epub 2015 Mar 24. J Steroid Biochem Mol Biol. 2015. PMID: 25817828 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials